Clinical and Molecular Hepatology

Correspondence to letter to the editor on “Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis”: Haiyu Wang, Jinjun Chen; Clin Mol Hepatol 2026;32(2):e238-e240.
Published online June 13, 2025; DOI: https://doi.org/10.3350/cmh.2025.0611

Correspondence to editorial 2 on “Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis”: Haiyu Wang, Jinjun Chen; Clin Mol Hepatol 2026;32(1):e62-e64.
Published online March 31, 2025; DOI: https://doi.org/10.3350/cmh.2025.0327

Citations

Citations to this article as recorded by

Correspondence to letter to the editor on “Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis”
Haiyu Wang, Jinjun Chen
Clinical and Molecular Hepatology.2026; 32(2): e238. CrossRef

Correspondence to editorial 1 on “Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis”: Haiyu Wang, Jinjun Chen; Clin Mol Hepatol 2026;32(1):e58-e61.
Published online March 31, 2025; DOI: https://doi.org/10.3350/cmh.2025.0326

Citations

Citations to this article as recorded by

Reply to correspondence on “Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis”
Mathias Jachs, Mattias Mandorfer
Clinical and Molecular Hepatology.2026; 32(1): e106. CrossRef
Correspondence to letter to the editor on “Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis”
Haiyu Wang, Jinjun Chen
Clinical and Molecular Hepatology.2026; 32(2): e238. CrossRef

The evolution of non-invasive strategies in cirrhosis management—from screening to precision monitoring: Editorial on “Fibrosis-4plus score: a novel machine learning-based tool for screening high-risk varices in compensated cirrhosis (CHESS2004): an international multicenter study”: Haiyu Wang, Jinjun Chen; Clin Mol Hepatol 2026;32(1):403-406.
Published online March 19, 2025; DOI: https://doi.org/10.3350/cmh.2025.0274

Citations

Citations to this article as recorded by

Correspondence to letter to the editor on “Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis”
Haiyu Wang, Jinjun Chen
Clinical and Molecular Hepatology.2026; 32(2): e238. CrossRef